Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients (AdVance)

Chimerix

Status: Completed

Conditions: Adenovirus Infections, Human

Study type: Observational

Funder types: Industry

Identifiers

NCT04285788

AdVance

Details and patient eligibility

About

To depict the incidence, outcomes and standards of care (SoC) of adenovirus (AdV) infections and associated practice patterns in allogeneic hematopoietic cell transplant recipients. It is expected that participating centers will be in the United Kingdom, France, Spain, Germany, and Italy.

Enrollment: 216 patients

Sex: All

Ages: Under 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least one AdV positive test, regardless of specimen within 6 months following the first allo-HCT
• Subjects first allo-HCT must have been performed between 1 January 2013 and 30 September 2015

Exclusion criteria

• AdV negative